-
Symbol
-
ABUS on Nasdaq
-
Investment type
-
Equity / Common Shares, without par value
-
Latest Disclosed Shares Owned
-
38,847,462 shares
-
Security Ownership %
-
20%
Roivant Sciences Ltd. ownership in Arbutus Biopharma Corp Common Shares, without par value (ABUS)
25 Feb 2025 - Roivant Sciences Ltd. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 38,847,462 shares of Arbutus Biopharma Corp Common Shares, without par value (ABUS).
This represents 20% ownership of the company.
In their previous filing dated 18 Feb 2025, Roivant Sciences Ltd. had reported owning 38,847,462 shares, indicating a new holding.